Hepatitis C virus-associated keratitis

Eye

Volumn 18, Issue 2, 2004, Pages 131-134

  Jain, A K ^a   Sukhija, J ^a   Saini, J S ^a   Chawla, Y ^a   Dhiman, R K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Hepatitis C; Mooren's ulcer

Indexed keywords

ADULT; AGE; AGED; ANAMNESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA ULCER; DISEASE ASSOCIATION; EYE INJURY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HERPES SIMPLEX KERATITIS; HUMAN; MALE; SCHOOL CHILD; SCREENING TEST; SEX RATIO; SLIT LAMP; VIRUS KERATITIS; VISUAL SYSTEM EXAMINATION;

EID: 1342346336     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6700604     Document Type: Article

References (33)

1. WHO. Global surveillance and control of hepatitis C. J Viral Hepatitis 1999; 6: 35-47.
2. Gordon SC. Extrahepatic manifestations of hepatitis C. Dig Dis 1996; 14: 157-168.
3. Hadziyannis S. Non-hepatic manifestations of chronic HCV infection. J Viral Hepatitis 1997; 4: 1-17.
4. Verbaan H, Carlson J, Eriksson S, Larsson A, Liedholm R, Manthorpe R et al. Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjogren's syndrome and hepatitis C in Swedish patients. J Intern Med 1999; 245: 127-132.
5. Wilson SE, Lee WM, Murakami C, Weng J, Moninger GA. Mooren's corneal ulcers and hepatitis virus C infection [letter]. N Engl J Med 1993; 329: 62.
6. Wilson SE, Lee WM, Murakami C, Weng J, Moninger GA. Mooren's type hepatitis C virus associated corneal ulceration. Ophthalmology 1994; 101: 736-745.
7. Moazami G, Auran JD, Florakis GJ, Wilson SE, Srinivasan DB. Interferon treatment of Mooren's ulcers associated with hepatitis C. Am J Ophthalmol 1995; 119: 365-366.
8. Baratz KH, Fulcher SFA, Bourne WM. Hepatitis C-associated keratitis. Arch Ophthalmol 1998; 116: 529-530.
9. Brown SI, Mondino BJ, Rabib BS. Autoimmune phenomenon in Mooren's ulcer. Am J ophthalmol 1976; 82: 835-840.
10. Wood TO, Kaufman HE. Mooren's ulcer. Am J Ophthalmol 1971; 71: 417-422.
11. Brown SI. What is Mooren's ulcer? Trans Ophthalmol Soc UK 1978; 98: 390-392.
12. Mondino BJ. Peripheral corneal ulcers and thinning disorders. Perspect Ophthalmol 1980; 4: 9-15.
13. Brown SI, Mondino BJ. Therapy of Mooren's ulcer. Am J Ophthalmol 1984; 98: 1-6.
14. Arentsen JJ, Christiansen JM, Maumenee AE. Marginal ulceration after intracapsular cataract extraction. Am J Ophthalmol 1976; 81: 194-197.
15. Salamon SM, Mondino BJ, Zaidman GW. Peripheral corneal ulcers, conjunctival ulcers, and scleritis after cataract surgery. Am J Ophthalmol 1982; 93: 334-337.
16. Gottsch JD, Liu SH, Stark WJ. Mooren's ulcer and evidence of stromal graft rejection after penetrating keratoplasty. Am J Ophthalmol 1992; 113: 412-417.
17. Mondino BJ, Brown SI, Mondzelewski JP. Peripheral corneal ulcers with herpes zoster ophthalmicus. Am J Ophthalmol 1978; 86: 611-614.
18. Cunningham Jr ET, Wilson SF. Link between Mooren's ulcer, hepatitis C is questioned. Associated flaviviruses could cause corneal problems, yet go undetected by available tests. Ocular Surgery News. 15 January, 2000.
19. Jaeckel E, Cornberg M, Wedemeyer H, Santantonio T, Mayer J, Zantiel M et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 2001; 345: 1452-1457.
20. Takada N, Takase S, Takada A. Effects of genotypes of hepatitis C virus on interferon treatment for chronic type C hepatitis. Gastroentrol Jpn 1993; 28: 268-275.
21. Lopez-Labrador FX, Ampurdanes S, Gimenez-Barcons M, Guilera M, Costa J, Jimenez de Anta MT et al. Relationship of genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1 b infection [correction of interferon]. Hepatology 1999; 29: 897-903.
22. Pluznik D, Butrus SI. Hepatitis C-associated peripheral corneal ulceration. Cornea 2001; 20: 888-889.
23. Naacke H, Borderie V, Touzeau O, Bourcier T, Scat Y, Laroche L. Marginal corneal perforation associated with herpes simplex virus in a patient with essential cutaneous porphyria. J Fr Ophtalmol 2000; 23: 699-702.
24. Sangwan VS, Zafirakis P. Foster S. Mooren's ulcer: current concepts in management. Indian J Ophthalmol 1997; 45: 7-17.
25. Kanai K, Iwata K, Nakao K, Kako M, Okamoto H. Suppression of hepatitis C virus RNA by interferon-alfa. Lancet 1990; 336: 245.
26. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC Jr, Perrilo RP et al. Treatment of chronic hepatitis with recombinant interferon alfa. A multicenter randomized, controlled trial. N Engl J Med 1989; 321: 1501-1506.
27. Schvacez R, Weiland O, Wejstal R, Norkans G, Fryden A, Foberg U. A randomized controlled open study of interferon alpha-2b treatment of chronic non-A, non-B posttransfusion hepatitis: no correlation of outcome to presence of hepatitis C virus antibodies. Scand J Infect Dis 1989; 21: 617-625.
28. Lambiase L, Davis GL. Treatment of chronic hepatitis. Gastroentrol Clin N Am 1992; 21: 659-677.
29. Tang E. Hepatitis C virus. A review. West J Med 1991; 155: 164-168.
30. Feucht H, Polywka S, Zollner B, Laufs R. Greater amount of HCV-RNA in tear compared to blood. Microbiol Immunol 1994; 38: 157-158.
31. Houghton M, Weiner A, Han J, Kuo G, Choo QL. Molecular biology of the hepatitis C virus: implications of diagnosis, development and control of viral diseases. Hepatology 1991; 14: 381-388.
32. Zegans ME, Srinivasan M, McHugh T, Whitcher JP, Margolis TP, Lietman T et al. Mooren's ulcer in south India: serology and clinical risk factors. Am J Ophthalmol 1999; 128(2): 205-210.
33. Leyland M, Torok ME, Acheson, Foster GR. Hepatitis C virus infection is not associated with a marked increase in the prevalence of ophthalmic morbidity. Eye 2000; 14: 889-891.